$DNA News
Last published 6d ago
- 6d agoDNAGinkgo Bioworks Holdings, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 6d agoDNAGinkgo Bioworks Q3 2026 Update & Business Review - GINKGO BIOWORKS HOLDINGS INCEarnings Call Transcriptsmanager of communications and ownership i'm joined by jason kelly our co-founder and ceo and steve cohen our cfo thanks as always for joining us we're looking forward to updating you on our progress as a reminder during
- 1mo agoDNAGinkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science ProgramBusiness WireGinkgo Bioworks (NYSE:DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to support the National Science Foundation’s X-Labs program. Ginkgo’s support was announced today by
- 1mo agoDNAAraceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-LoopPR NewswireThe Endeavor® adds the fastest high-content cellular data generation to Ginkgo's around-the-clock research PORTLAND, Ore. and BOSTON, Oct. 8, 2026 /PRNewswire/ -- Araceli Biosciences and Ginkgo Bioworks (NYSE:DNA)
- 1mo agoDNAGinkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability ConsortiumBusiness WireGinkgo generates antibody data at scale and trains models for drug manufacturability and developability. Apheris’ federated infrastructure enables participating pharmaceutical companies to use those models and further
- 1mo agoDNAGinkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab DataBusiness WireIntegration puts Ginkgo’s biological data generation services at the heart of the industry’s most prominent AI-driven drug discovery network Ginkgo Bioworks (NYSE:DNA) today announced that its Ginkgo Datapoints
- 2mo agoDNAGinkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA MedicinesBusiness WireGinkgo plans to build the automation hardware and control software for ESCALATOR, a continuous-flow, autonomous manufacturing system designed to produce and quality-release RNA drug products at patient scale Ginkgo
- 3mo agoDNAEarnings Call - GINKGO BIOWORKS HOLDINGS INCEarnings Call TranscriptsI'm Daniel Marshall, senior manager of communications and ownership. I'm joined by Jason Kelly, our co-founder and CEO, and Steve Cohen, our CFO. Thanks as always for joining us. We're looking forward to updating you on
- 5mo agoDNAGinkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug DiscoveryPR NewswireGinkgo Bioworks (NYSE: DNA) today announced that its Datapoints offering is launching ADME-One™, a fully integrated ADME platform for drug discovery...
- 6mo agoHIMSNVOMNKDDNAThe $59B Quiet Shift Reshaping How Patients Access CarePR NewswirePoint-of-care diagnostics just crossed $58.76 billion globally in 2026, growing at nearly 10% annually as testing that used to require a hospital lab ...
- 6mo agoDNAGinkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous LabPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the first quarter of 2026 that ended March 31, 2026. The update, ...
- 6mo agoDNAGinkgo Bioworks Announces Date of First Quarter 2026 Results PresentationPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business...
- 8mo agoDNAGinkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab InfrastructurePR NewswireGinkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their...
- 8mo agoDNAGinkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity BusinessPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the fourth quarter and full year ended December 31, 2025. The...
- 8mo agoDNAGinkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results PresentationPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business...
- 8mo agoDNAGinkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural ProductsPR NewswireGinkgo Bioworks (NYSE: DNA, "Ginkgo") and Invaio Sciences, an agricultural biotechnology company leading in nature-positive crop protection...
- 9mo agoDNAGinkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific BenchmarkPR NewswireGinkgo Bioworks (NYSE: DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and ...
- 10mo agoDNAGinkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare ConferencePR NewswireGinkgo Bioworks (NYSE: DNA) announced today that Co-Founder and CEO Jason Kelly is scheduled to present at the 44th Annual J.P. Morgan Healthcare...
- 10mo agoDNAGinkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening ApproachPR NewswireGinkgo Bioworks (NYSE: DNA) today announced its partnership with Carnegie-Mellon University (CMU) for an award by the Advanced Research Projects...
- 10mo agoDNAGinkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil AmendmentPR NewswireGinkgo Bioworks (NYSE: DNA, "Ginkgo"), a provider of research and development services and tools for biological product development and Agricen, a...
- 11mo agoDNAProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus TherapiesGlobeNewswireLeiden, The Netherlands – 11 December 2025 – ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic® technology
- 11mo agoDNAGinkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safetyPR NewswireGinkgo Bioworks (NYSE: DNA) today announced its partnership with Deep Origin on a 4.5-year project funded by the Advanced Research Projects Agency...
- 11mo agoDNAGinkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PCPR NewswireGinkgo Bioworks (NYSE: DNA) today announced it has been awarded by the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest...
- 11mo agoDNAGinkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral HealthPR NewswireGinkgo Bioworks (NYSE: DNA) today announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on...
- 1y agoDNAGinkgo Bioworks Reports Third Quarter 2025 Financial ResultsPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the third quarter ended September 30, 2025. The update,...
- 1y agoASTRBACQDNAMerlin Appoints Ryan Carrithers as Chief Financial Officer, Increasing Public Market ReadinessBusiness WireCarrithers brings to Merlin a unique blend of technical expertise, capital markets experience, and operational rigor, backed by a proven record in scaling innovative automation and aerospace companies Merlin Labs,
- 1y agoDNADCIGinkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-ConsortiumPR NewswireGinkgo Bioworks (NYSE: DNA) announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority's...
- 1y agoDNAGinkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for AgriculturePR NewswireGinkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to advance research and...
- 1y agoDNAGinkgo Bioworks Announces Date of Third Quarter 2025 Results PresentationPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business...
- 1y agoDNAGinkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY ProgramPR NewswireGinkgo Bioworks (NYSE: DNA) today announced a collaboration with STRM.BIO and the University of British Columbia (UBC) as part of the Advanced...
- 1y agoONCZLABCRVSDNA+2The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive PartnersPR NewswireThe Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of...
- 1y agoDNAGinkgo Datapoints and Apheris Launch Antibody Developability ConsortiumBusiness WireGinkgo to Run AbDev AI Competition Ginkgo Bioworks (NYSE:DNA) today announced a series of new initiatives from its Datapoints offering to accelerate the application of artificial intelligence in biologics drug
- 1y agoDNAGinkgo Bioworks Issues Notice of Settlement of Shareholder Derivative ActionsPR NewswireGinkgo Bioworks (NYSE: DNA) today released the following notice: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA OAKLAND DIVISION...
- 1y agoDNAGinkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma IndustryPR NewswireGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that its Datapoints...
- 1y agoDNAGinkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External GrowthPR NewswireGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the appointment of...
- 1y agoDNAGinkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoDNAGinkgo Bioworks Reports Second Quarter 2025 Financial ResultsPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced...
- 1y agoDNAGinkgo Bioworks Announces Date of Second Quarter 2025 Results PresentationPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced...
- 1y agoDNAGinkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the BioeconomyPR NewswireGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that the Environmental...
- 1y agoDNAGinkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International VendorsPR NewswireGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the launch of a powerful...
- 1y agoDNAGinkgo Bioworks Announces Appointment of Steven Coen as Chief Financial OfficerPR NewswireGinkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity, today announced...
- 1y agoDNATWSTTwist Bioscience and Ginkgo Bioworks Revise CollaborationBusiness WireNew terms provide Twist with key license to long DNA technology and assets Ginkgo to continue ordering from Twist with no purchase minimums Twist Bioscience Corporation (NASDAQ:TWST), a core mid-cap growth and value
- 1y agoDNAGinkgo Bioworks Reports First Quarter 2025 Financial ResultsPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced...
- 1y agoDNAPhytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative ColorsPR NewswirePhytolon, a biotech-foodtech startup that offers natural food colors via fermentation of baker's yeast, and Ginkgo Bioworks (NYSE: DNA, "Ginkgo"),...
- 1y agoDNAGinkgo Bioworks Announces Date of First Quarter 2025 Results PresentationPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced...
- 1y agoDNAGinko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and InnovationPR NewswireGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Ginkgo Automation will ...
- 1y agoDNADCIGinkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of GrainPR NewswireGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new contract with the...
- 1y agoDNAGinkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial ResultsPR NewswireGinkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced...
- 1y agoDNAGinkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput labPR NewswireVolta Labs, a leading genomics applications company, and Ginkgo Bioworks, (NYSE: DNA), which is building a leading platform for cell programming and...
- 1y agoDNAGinkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of CarePR NewswireGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a collaboration with the...